enalapril/lercanidipine pharmaswiss 10 mg/10 mg apvalkotās tabletes
pharmaswiss ceska republika s.r.o., czech republic - enalaprili maleas, lercanidipini hydrochloridum - apvalkotās tabletes - 10 mg/10 mg
enalapril/lercanidipine pharmaswiss 20 mg/10 mg apvalkotās tabletes
pharmaswiss ceska republika s.r.o., czech republic - enalaprili maleas, lercanidipini hydrochloridum - apvalkotās tabletes - 20 mg/10 mg
lopinavir/ritonavir accord 200 mg/50 mg apvalkotās tabletes
accord healthcare b.v., netherlands - lopinavirum, ritonavirum - apvalkotā tablete - 200 mg/50 mg
elernap 10 mg/10 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - enalaprili maleas, lercanidipini hydrochloridum - apvalkotā tablete - 10 mg/10 mg
elernap 20 mg/10 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - enalaprili maleas, lercanidipini hydrochloridum - apvalkotā tablete - 20 mg/10 mg
rubraca
pharmaand gmbh - rucaparib kamsilāts - olnīcu jaunveidojumi - antineoplastiski līdzekļi - rubraca is indicated as monotherapy for the maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. rubraca ir norādīts kā monotherapy uzturēšanas ārstēšanai pieaugušiem pacientiem ar platīna-jutīga relapsed augstas kvalitātes epitēlija olnīcu, olvados, vai primāro peritoneālās vēzi, kas ir atbildes reakcija (pilnīgu vai daļēju), platīna ķīmijterapiju.
sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 un 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 un 5.
lercapin ace 20 mg/20 mg apvalkotās tabletes
recordati ireland limited, ireland - enalaprili maleas, lercanidipini hydrochloridum - apvalkotā tablete - 20 mg/20 mg
lercaprel 20 mg/20 mg apvalkotās tabletes
recordati ireland limited, ireland - enalaprili maleas, lercanidipini hydrochloridum - apvalkotā tablete - 20 mg/20 mg
lercapin ace 10 mg/10 mg apvalkotās tabletes
recordati ireland limited, ireland - enalaprili maleas, lercanidipini hydrochloridum - apvalkotā tablete - 10 mg/10 mg